BACKGROUND
Racial disparities in prostate cancer (PCa) survival are inconsistently reported.
METHODS
We evaluated long-term survival in 976 men from the NCI-Maryland PCa case-control study, stratified by disease stage.
RESULTS
There were no survival differences observed between African American (AA) and European Am...
T. Minas, E. Butler, SM Mwamburi et al.· The Prostate· 0 citations
Alterations in peripheral immunity may contribute to fatal prostate cancer and the excessive disease burden among African American (AA) men. Thus, we investigated peripheral immunity in prostate cancer patients in association with disease outcome and AA descent. We performed single-cell RNA and T cell receptor (TCR) se...
Huai-Tian Liu, Alexandra R. Harris, Tiffany H. Dorsey et al.· Cancer immunology research· 0 citations
This review discusses ACR dysregulation in PCa through both mutational and non-mutational mechanisms, illustrated by discussing how the functional consequences are highly context-dependent, varying with disease stage, prior treatment exposure, and tumor ancestry.
Lillian M. Torres, Clayton C. Yates, C. Bevan et al.· Endocrinology· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.